中国现代应用药学2024,Vol.41Issue(3) :428-438.DOI:10.13748/j.cnki.issn1007-7693.20222960

聚山梨酯在治疗性抗体中应用和引发不溶性颗粒的研究概况

Overview of the Application of Polysorbates in Therapeutic Antibody and Its Induction of Insoluble Particles

李英 李加齐 姚雪静 王海钠
中国现代应用药学2024,Vol.41Issue(3) :428-438.DOI:10.13748/j.cnki.issn1007-7693.20222960

聚山梨酯在治疗性抗体中应用和引发不溶性颗粒的研究概况

Overview of the Application of Polysorbates in Therapeutic Antibody and Its Induction of Insoluble Particles

李英 1李加齐 2姚雪静 2王海钠3
扫码查看

作者信息

  • 1. 山东大学药学院,济南 250012;荣昌生物制药(烟台)股份有限公司,山东烟台 264006
  • 2. 荣昌生物制药(烟台)股份有限公司,山东烟台 264006
  • 3. 山东大学药学院,济南 250012
  • 折叠

摘要

聚山梨酯是治疗性抗体开发中常用的一类非离子型表面活性剂.近年来,因聚山梨酯能够引发治疗性抗体溶液中不溶性颗粒的产生,使其受到业界的关注.本文综述了聚山梨酯在治疗性抗体开发中的应用和其导致不溶性颗粒的风险点,即聚山梨酯的自身质量、接触材质、降解;然后本文提出了使用色谱法监控聚山梨酯质量是更有利的技术;最后基于目前的研究提出解决此类不溶性颗粒的思路和其中现存的挑战,为聚山梨酯在治疗性抗体中应用前景做出参考.

Abstract

Polysorbate is a commonly used non-ionic surfactant in the development of therapeutic antibodies.In recent years,polysorbate has attracted industry attention due to its ability to induce the production of insoluble particles in therapeutic antibody solutions.This article offers a comprehensive synopsis of polysorbate's role in therapeutic antibody development and associated risks of insoluble particle formation,including its intrinsic mass,interacting material,and degradation.Subsequently,the merits of employing chromatography to supervise polysorbate quality are underscored.Finally,based on current research,a solution to this type of insoluble particle and the existing challenges are proposed,providing reference for the application prospects of polysorbate in therapeutic antibodies.

关键词

聚山梨酯/治疗性抗体/应用/质量/降解/不溶性颗粒

Key words

polysorbates/therapeutic antibody/application/quality/degradation/insoluble particles

引用本文复制引用

出版年

2024
中国现代应用药学
中国药学会

中国现代应用药学

CSTPCDCSCD北大核心
影响因子:0.877
ISSN:1007-7693
参考文献量85
段落导航相关论文